PNEUMOCOCCAL VACCINES
Clinical trials for PNEUMOCOCCAL VACCINES explained in plain language.
Never miss a new study
Get alerted when new PNEUMOCOCCAL VACCINES trials appear
Sign up with your email to follow new studies for PNEUMOCOCCAL VACCINES, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New 31-Strain pneumonia vaccine shows promise in large trial
⭐️ VACCINE ⭐️ OngoingThis study tests a new vaccine called VAX-31 to see if it is safe and creates a strong immune response against pneumonia-causing bacteria. About 4,000 healthy adults aged 50 and older, plus some younger adults, will receive either VAX-31 or an existing vaccine. Researchers will c…
Matched conditions: PNEUMOCOCCAL VACCINES
Phase: PHASE3 • Sponsor: Vaxcyte, Inc. • Aim: ⭐️ VACCINE ⭐️
Last updated May 17, 2026 11:50 UTC
-
New baby vaccine aims to beat pneumonia
⭐️ VACCINE ⭐️ OngoingThis study tests a new vaccine called VAX-31 to protect babies against pneumococcal disease, which can cause pneumonia and meningitis. About 905 healthy infants will receive four doses of VAX-31 or a current vaccine at 2, 4, 6, and 12-15 months old. Researchers will check for sid…
Matched conditions: PNEUMOCOCCAL VACCINES
Phase: PHASE2 • Sponsor: Vaxcyte, Inc. • Aim: ⭐️ VACCINE ⭐️
Last updated May 08, 2026 12:03 UTC
-
New combo shot study: could one visit protect against 31 pneumonia strains and flu?
Prevention OngoingThis study tests a new vaccine called VAX-31, which targets 31 types of bacteria that cause pneumonia and other infections. Researchers want to see if it is safe and works well when given at the same time as the seasonal flu shot in healthy adults aged 50 and older. About 1,390 p…
Matched conditions: PNEUMOCOCCAL VACCINES
Phase: PHASE3 • Sponsor: Vaxcyte, Inc. • Aim: Prevention
Last updated May 07, 2026 18:41 UTC